期刊文献+

慢性肝病的抗纤维化治疗 被引量:2

Antifibrotic therapy in chronic hepatic diseases
暂未订购
导出
摘要 纤维化是机体创伤修复的一种类型,各种类型的肝脏疾病均可引起肝纤维化最终导致肝硬化。星状细胞是肝纤维化形成的中心环节,其活化的主要特征之一是合成大量的细胞外基质。近年来的研究证实,肝纤维化和早期肝硬化是可逆的,此文综述肝纤维化形成机制,并探讨目前及将来抗肝纤维化的治疗方法。 The response to injury is one of wound healing and subsequently fibrosis, Injury and wounding lead to cirrhosis ultimately in many patients (although not all patients). Recent literature indicates that the hepatic stellate cell is the central component in the fibrogenie process. Stellate cells undergo a transformation during injury that has been termed activation. Activation is complex and multifaceted, hut one of its most prominent features is the synthesis of large amounts of extracellular matrix. It is noteworthy that even advanced fibrosis (or cirrhosis) is reversible. This article emphasizes mechanisms underlying fibrogenesis, and reviews current antifibrotie therapies as well as potential future approaches.
出处 《国际消化病杂志》 CAS 2007年第1期24-27,共4页 International Journal of Digestive Diseases
关键词 肝纤维化 星状细胞 细胞因子 治疗 Hepatic fibrosis Hepatic stellate cell Cytokine Therapy
  • 相关文献

参考文献17

  • 1Schnabl B,Kweon YO,Frederick JP,et al.The role of Smad3 in mediating mouse hepatic stellate cell activation.Hepatology,2001,34:89-100
  • 2Gaca MDA,Georges P,Jammey P,et al.Matrix compliance determines hepatic stellate cell phenotype.Hepatology,2003,38:776A
  • 3Garcia-Banuelos J,Siller-Lopez F,Miranda A,et al.Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors.Evidence of cirrhosis reversion.Gene Ther,2002,9:127-134
  • 4Wright MC,Issa R,Smart DE,et al.Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.Gastroenterology,2001,121:685-698.
  • 5Canbay A,Taimr P,Torok N,et al.Apoptotic body engulfment by a human stellate cell line is profibrogenic.Lab Invest,2003,83:655-663
  • 6Neuschwander-Tetri BA,Brunt EM,Wehmeier KR,et al.Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.Hepatology,2003,38:1008-1017.
  • 7Rambaldi A,Gluud C.Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis.Liver,2001,21:129-136
  • 8Nelson DR,Tu Z,Soldevila-Pico C,et al.Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.Hepatology,2003,38:859-868
  • 9Muir AJ,Sylvestre PB,Rockey DC.Interferon gamma-1b for the treatment of chronic hepatitis C infection.Gastroenterology,2003,124:718
  • 10Poupon RE,Lindor KD,Pares A,et al.Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.J Hepatol,2003,39:12-16

二级参考文献3

共引文献6

同被引文献16

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部